Clinical Trials
3
Active:1
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)A Study to Investigate the Interaction Between TMP-301 and Cocaine.
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Tempero Bio, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT06648668
- Locations
- 🇺🇸
Dr. Vince Clinical Research, Overland Park, Kansas, United States
A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder
Phase 2
Active, not recruiting
- Conditions
- Alcohol Use Disorder (AUD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Tempero Bio, Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT06648655
- Locations
- 🇺🇸
Headlands Research, Scottsdale, Arizona, United States
🇺🇸Yale School of Medicine, New Haven, Connecticut, United States
🇺🇸Research Centers of America, LLC, Hollywood, Florida, United States
Multiple Ascending Dose Study of TMP-301 in Healthy Subjects
Phase 1
Completed
- Conditions
- Cocaine Use DisorderSubstance Use DisordersHealthy Volunteers
- Interventions
- Drug: Cohort 1 - TMP-301Drug: PlaceboDrug: Cohort 2 - TMP-301Drug: Cohort 3 - TMP-301Drug: Cohort 4 - TMP-301
- First Posted Date
- 2023-09-06
- Last Posted Date
- 2025-07-29
- Lead Sponsor
- Tempero Bio, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06025396
- Locations
- 🇺🇸
Altasciences, Overland Park, Kansas, United States
News
No news found